Search

everythinglearnresearchcommunity

for

Search:↓

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Laser-assisted drug delivery is generally safe with mostly mild side effects.

Epristeride's metabolism in zebrafish helps improve doping detection methods.

DHEA reduction may be linked to frontal fibrosing alopecia, but more research is needed.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

Arabidopsis Formin 2 stabilizes actin filaments, affecting cell-to-cell movement and virus susceptibility.

The KRTAP22-2 gene in sheep does not significantly affect wool traits.

The AUTS2 gene is linked to neurological disorders and may affect human brain development and cognition.

Basic drugs like amphetamine are absorbed more in darker hair than lighter hair.

PAD3 plays a key role in hair and skin protein structure and may be linked to skin diseases.

Adenosine helps hair grow longer and stronger by boosting certain growth factors and signaling pathways.

CO2 fractional laser treatment helped regrow hair in a 13-year-old with alopecia areata.

Diffuse alopecia areata causes widespread hair thinning due to an autoimmune response.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Dauricine may help treat certain brain cancers by reducing cancer cell growth and promoting cell death.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

Topical adenosine may effectively and safely treat hair loss.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

High CRP levels could indicate vitamin D deficiency in people with alopecia areata.

A girl with skin rashes and low zinc levels improved with zinc supplements and had new gene mutations linked to her condition.

DHT enhances androgen receptor activity more than testosterone, and MAGE-11 influences this activity through specific interactions.

A new microneedle patch effectively treats hair loss by delivering growth factors to the skin.

JAM-A helps hair regrowth in alopecia areata by protecting VCAN in skin cells.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

A comprehensive approach is needed to accurately assess alopecia areata severity and guide treatment decisions.

A new method helps diagnose alopecia areata using specific gene markers and could guide targeted treatments.

Topical 4-aminopyridine 5% does not improve hair growth in male pattern baldness.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Farudodstat can prevent hair follicle immune damage linked to alopecia areata.